Last reviewed · How we verify
Withdrawal of furosemide — Competitive Intelligence Brief
marketed
Cardiovascular
Small molecule
Live · refreshed every 30 min
Target snapshot
Withdrawal of furosemide (Withdrawal of furosemide) — Unity Health Toronto. Withdrawal of furosemide allows restoration of normal fluid and electrolyte balance by discontinuing loop diuretic activity.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Withdrawal of furosemide TARGET | Withdrawal of furosemide | Unity Health Toronto | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Withdrawal of furosemide CI watch — RSS
- Withdrawal of furosemide CI watch — Atom
- Withdrawal of furosemide CI watch — JSON
- Withdrawal of furosemide alone — RSS
Cite this brief
Drug Landscape (2026). Withdrawal of furosemide — Competitive Intelligence Brief. https://druglandscape.com/ci/withdrawal-of-furosemide. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab